在使用通用数据模型的多中心研究中,他类药物的使用对头癌预后的影响
Soobeen Seol1, Jung Ran Choi2, Byungjin Choi1
1Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.
Scientific reports
|November 13, 2023
概括
这项研究调查了他类药物的使用和头癌 (HNC) 复发情况. 虽然他类药物显示出减少复发的趋势,但在这个队列中,这种关联在统计学上并不显著.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于他类药物使用对头癌 (HNC) 结果的影响的研究有限.
- 了解他类药物在HNC管理中的潜在益处对于患者护理至关重要.
结论:
- 这项倾向匹配的队列研究没有发现他类药物使用与较低HNC复发风险之间的统计学上显著联系.
- 建议进行进一步的大规模追溯和前性研究,以澄清他类药物在HNC中的作用.
- 全国索赔数据可以提供更强有力的证据.
相关概念视频
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


